Life Sciences Consulting Case Interview Practice
Life sciences consulting case interview practice tests how you solve pharmaceutical and biotech business problems using logic built for this client rather than memorized frameworks. McKinsey's official GlobaPharm practice case walks through a $10 billion pharmaceutical company evaluating the $1 billion acquisition of a biologicals start-up, including drug pipeline valuation and a $150 million Phase II clinical trial break-even calculation without a calculator. Read the prompts below, take notes on paper, and say your answers out loud to simulate the real interview.
Updated
What McKinsey and BCG test in a life sciences case
Both McKinsey and BCG use the case interview, which they also call the problem-solving interview, to see how you approach a realistic client scenario. Neither firm looks for a single right answer or a memorized formula. McKinsey states on its interviewing page that candidates should listen carefully and share tailored solutions rather than standard frameworks, which you can rehearse in our McKinsey case interview guide. BCG case interview preparation gives the same rule: what matters most is how you approach the problem and the quality of your reasoning.
When you work through a pharmaceutical or biotech prompt, you follow the same step-by-step reasoning BCG outlines for every client-facing candidate. You structure your approach, ask thoughtful questions, analyze data, run calculations on paper, and pull out the factors that drive the decision. Throughout the case, you show your thinking out loud so the interviewer can follow your logic.
You can start right now: Practice a case free, no sign-up, or work through McKinsey's GlobaPharm practice case step by step in the next section.
- Do listen actively, be yourself, think structurally, communicate clearly, clarify assumptions, and show your thinking (BCG case interview preparation).
- Do not panic under pressure, rush your response, overcomplicate solutions, ignore feedback, stay silent, or interrupt (BCG case interview preparation).
- Keep pen and paper ready and put your calculator away. McKinsey does not allow calculators during interviews, so you write out your arithmetic on paper and talk the interviewer through your steps.
How McKinsey and BCG structure their consulting interview processes
| Stage | McKinsey & Company | Boston Consulting Group (BCG) |
|---|---|---|
| Pre-interview assessment | Solve, a gamified assessment that tests natural problem-solving abilities for most consulting roles | Cognitive test in select locations |
| Experience and behavioral | Personal Experience Interview (PEI) covering accomplishments, challenges, your specific role, and your reasoning | Skills Interview exploring your experience, skills, and motivation, relating answers back to job requirements |
| Case and problem solving | Problem-Solving Interview presenting a client business case to evaluate your approach to complex problems | Case Interview and Team Interview assessing problem-solving, analytical, and communication skills |
| Role-specific deep dive | Expertise Interview for select roles to evaluate how your specific experience and skill set fit the role | Two-way conversation exploring your experience, strengths, and aspirations |
Practice out loud: McKinsey's GlobaPharm biologicals case
McKinsey publishes an official life sciences practice case called GlobaPharm. It covers market entry into biologics, M&A strategy, R&D pipeline evaluation, clinical trial break-even math, and post-merger R&D integration. Instead of reading it silently, grab a pen and paper and rehearse the four prompts out loud, then try more prompts on our consulting case study examples page.
Here is the client setup from McKinsey's GlobaPharm case. Your client is GlobaPharm, a major pharmaceutical company headquartered in Germany with primary R&D centers in Germany, regional sales offices worldwide, and $10 billion in annual revenue. GlobaPharm has a long history in small-molecule drugs, such as aspirin and most blood-pressure or cholesterol medications. Now it wants to enter biologicals, a rapidly growing segment of proteins or other large, complex molecules that treat conditions traditional drugs cannot address.
Biologicals R&D is vastly different from small-molecule R&D. To gain these capabilities, pharmaceutical companies have three options: build them from scratch, partner with existing start-ups, or acquire the start-ups. Because competitors are already several years ahead, GlobaPharm wants to jumpstart its biologicals program by acquiring BioFuture, a biologicals start-up in the San Francisco area. BioFuture was founded 12 years ago by prominent scientists, employs 200 people, is publicly traded, and is valued at about $1 billion at its current share price. GlobaPharm has asked McKinsey to answer one overarching question: Should GlobaPharm acquire BioFuture?
- Question 1 (Acquisition factors): What factors should the team consider when evaluating whether GlobaPharm should acquire BioFuture? McKinsey's hint: take time to organize your thoughts before answering, and develop an overall approach before diving into details.
- Question 2 (Drug pipeline value): The team decides to focus first on evaluating the value of BioFuture's current drug portfolio. What issues should the team consider when evaluating the value of BioFuture's existing drug pipeline? McKinsey's hint: mention a range of potential issues to explore instead of immediately diving deep into one issue, then ask your interviewer if they want to go deeper on any of them specifically.
- Question 3 (Phase II clinical trial break-even): GlobaPharm believes the likelihood of success of BioFuture's primary drug candidate can be improved by investing an additional $150 million in a larger Phase II trial, raising the Phase II success rate so more candidate drugs reach Phase III and Filing. McKinsey defines Filing as submitting all clinical and safety evidence from Phase I, II, and III trials and asking for regulatory approval to sell the drug. Assuming a successfully marketed and sold drug is worth $1.2 billion in present value of all future profits, by how much would the Phase II success rate need to increase for the $150 million investment to break even? McKinsey's hint: take notes of the numbers, take time to plan your approach, and talk the interviewer through your calculation.
- Question 4 (R&D integration risks): Although BioFuture's existing pipeline is relatively limited, GlobaPharm wants BioFuture to serve as a biological research engine that, combined with GlobaPharm's existing R&D assets, will produce many candidate drugs over the next 10 years. What are your hypotheses on the major risks of integrating the R&D functions of BioFuture and GlobaPharm?
Worked math example: solving the Phase II break-even question
In Question 3 of the GlobaPharm case, McKinsey gives you two hard dollar numbers in the prompt: an additional $150 million investment in Phase II, and a $1.2 billion present value of future profits if the drug is approved and sold. In a live interview, the interviewer also shows you a chart of expected probabilities of success by stage across Phase I, Phase II, Phase III, and Filing.
First, compare the two dollar figures directly. By our calculation from the GlobaPharm prompt, dividing the $150 million investment by the $1.2 billion present value of future profits equals 0.125, or 12.5 percentage points. That 12.5 percentage point increase is the required gain in the overall probability of reaching market and selling the drug.
Because a drug that passes Phase II must still pass Phase III and regulatory Filing before it can be sold, the Phase II success rate itself must rise by more than 12.5 percentage points. Below is an example written by our team showing how to walk your interviewer through that two-step math on paper once they hand you the Phase III and Filing rates.
- Step 1 (State the break-even equation out loud): The $150 million investment breaks even when the expected value added equals $150 million. Expected value added is the $1.2 billion payout multiplied by the increase in the probability of launching the drug.
- Step 2 (Find the required increase in overall launch probability): Divide $150 million by $1,200 million. Both numbers are in millions, so simplify 150 over 1,200 to 15 over 120, which equals 1 over 8, or 12.5 percentage points.
- Step 3 (Adjust for Phase III and Filing attrition, using illustrative probabilities chosen by our team): Suppose the interviewer's exhibit shows a 50% success rate in Phase III and an 80% success rate in Filing. A candidate drug that clears Phase II then has a 50% times 80%, or 40%, chance of eventually reaching the market.
- Step 4 (Solve for the Phase II increase): Divide the 12.5 percentage point required overall gain by the 40% downstream success rate (12.5 divided by 0.40). In this illustrative example, the Phase II success rate must increase by 31.25 percentage points for the $150 million trial expansion to break even.
How to communicate each step of your case answer
Knowing the science or the arithmetic is only half the task. Both McKinsey and BCG score how you organize your thoughts and involve the interviewer in the conversation. When you practice out loud, check your delivery against the communication habits both firms publish on their careers pages.
Start by pausing before you speak. On Question 1 of GlobaPharm, McKinsey explicitly notes that taking time to organize your thoughts tells the interviewer you think about the problem in a logical way. Write your main branches on paper first, state your overall approach at the top, and only then walk through the details.
When a prompt asks you to explore a broad area like a drug pipeline (Question 2), resist the urge to lecture on one scientific mechanism. Lay out the full menu of business and clinical issues first, then ask the interviewer where they want to go deeper. During the quantitative portion (Question 3), describe your approach and talk the interviewer through your calculation as you write.
- Ask for clarification whenever a term or number is unclear. McKinsey notes in GlobaPharm that you should feel free to ask the interviewer for an explanation of any point that is not clear, and in virtual interviews you should ask the interviewer to repeat any unclear question.
- Keep your solutions built for the client in the prompt. If the client is a $10 billion German small-molecule manufacturer buying a 200-person San Francisco biologicals start-up, your integration risks in Question 4 should reflect that specific gap in company size, geography, and scientific culture.
- See how a scored mock breaks down your structure, math, and synthesis: see a real sample report.
How PhDs, MDs, and life sciences specialists fit into the process
If you hold an advanced degree in biological sciences, medicine, or pharmacy, you go through the same core problem-solving and behavioral evaluations as other consulting candidates. McKinsey seeks problem-solvers from disciplines including medicine, engineering, and law, and professionals with PhDs, MDs, JDs, and other advanced degrees join from academia, research, or clinical practice into roles such as Associate, Fellow, or Summer Associate, while experienced Life Sciences leaders bring an advanced degree in biological and biomedical sciences alongside functional expertise in R&D or Operations. Alongside your case prep, set aside time for behavioral and PEI interview practice.
- Prepare for the Personal Experience Interview (PEI) at McKinsey: discuss important experiences in detail, focus on your specific role, and lead with your reasoning rather than actions.
- Prepare for the Skills Interview at BCG: review your past experiences and relate your behavioral answers directly back to the requirements of the consulting job.
- Prepare for an Expertise Interview: McKinsey uses this round for select roles to understand how your specific experience and skill set will enable you to excel in the role.
Using AI responsibly and setting up your practice space
Consulting firms encourage candidates to use AI during interview preparation while banning it during live assessments and interviews. McKinsey encourages using AI to practice interview questions and asking AI to explain concepts or frameworks as part of your prep, while strictly prohibiting generating real-time responses during an interview.
- Free official self-study tools: McKinsey provides sample practice cases on its interviewing page, and BCG offers a free job simulation called OneDay@BCG plus an online case library for candidates.
4-step checklist to rehearse a life sciences case tonight
Use this checklist written by our team to turn the official McKinsey and BCG rules into a 30-minute practice session. Do every step out loud with pen and paper.
- Step 1 (2 minutes, Structure Question 1): Read the GlobaPharm background out loud. Take time to organize your thoughts on paper, then state your overall approach for evaluating whether GlobaPharm should acquire BioFuture before naming specific details.
- Step 2 (3 minutes, Scope Question 2): List a broad range of clinical, commercial, and competitive issues to evaluate BioFuture's existing drug portfolio. End your answer by asking the interviewer which specific issue they would like to explore deeper.
- Step 3 (5 minutes, Calculate Question 3 on paper): Put away your calculator. Write down $150 million and $1.2 billion, plan your arithmetic, and talk through the break-even Phase II success rate calculation out loud step by step.
- Step 4 (5 minutes, Hypothesize Question 4 and synthesize): State clear hypotheses on the risks of integrating a 200-person San Francisco biologicals start-up with a $10 billion German small-molecule R&D organization over a 10-year horizon. Practice a case free, no sign-up to get your structure, math, and communication scored out loud.
From McKinsey & Company: Interviewing and Practice Cases, McKinsey & Company: GlobaPharm Practice Case, BCG Careers: Consulting Case Study Interview Preparation, BCG Careers: Consulting Interview Process, BCG Switzerland: Application and Interviews, McKinsey & Company: Advanced Professional Degree Careers and McKinsey & Company: Associate Partner - Life Sciences (Job ID 94349).
1 practice question and sample answer
Say your answer out loud first, then read the sample answer.
Practice question
GlobaPharm ($10 billion annual revenue, small-molecule focus in Germany) wants to jumpstart its entry into biologicals by acquiring BioFuture, a 200-person biologicals start-up in the San Francisco area valued at $1 billion. What factors should the team consider when evaluating whether GlobaPharm should acquire BioFuture, and what issues would you look at first to value BioFuture's current drug pipeline?
Sample answer. Example answer written by our team. The applicant is invented. "To decide whether GlobaPharm should acquire BioFuture for $1 billion, I would organize our approach into three main areas before diving into the details. First, the standalone value of BioFuture's current drug portfolio and its biological research engine. Second, the strategic fit and synergies with GlobaPharm's global sales offices and German R&D assets, including the risks of integrating a 200-person San Francisco start-up into a $10 billion small-molecule organization. Third, how acquisition compares against GlobaPharm's other two options: building biologicals R&D from scratch or partnering with existing start-ups. To evaluate BioFuture's existing drug pipeline first, I would explore four potential issues: the number of drug candidates currently in Phase I, Phase II, Phase III, and Filing, the expected probability of success and trial cost at each stage, the therapeutic conditions targeted and whether they face biologicals competitors that are already years ahead, and the present value of future profits if approved. Would you like me to go deeper into the clinical trial probabilities or the market potential of the primary candidate first?"
This response follows McKinsey's exact hints on the GlobaPharm case page. It states an organized overall approach before diving into details, incorporates the three build-partner-acquire options from the prompt, lists a range of pipeline issues rather than tunneling into a single scientific detail, and asks the interviewer which area to explore deeper.
Practice the case interview, out loud
Soreno's AI interviewer runs a full case one question at a time, checks your math and scores your structure, any time you have 30 minutes.
Questions people ask
Do I need to memorize a specific framework for a life sciences consulting case interview?
No. Both McKinsey and BCG state that there is no single logical or right answer in a case interview. McKinsey advises candidates to listen carefully and share tailored solutions rather than standard frameworks, and BCG notes that interviewers value analysis and logic over memorized solutions.
Are calculators allowed during pharmaceutical case interview math?
No. McKinsey states in its GlobaPharm practice case instructions that calculators are not allowed during interviews, though you may write out your calculations on paper and talk the interviewer through your approach.
Can I use AI to practice for my consulting case interview?
Yes, for preparation only. McKinsey encourages candidates to use AI to practice interview questions and to explain concepts or frameworks during prep, but strictly prohibits using AI to generate real-time answers during an interview.
What is McKinsey's GlobaPharm practice case about?
GlobaPharm is an official McKinsey practice case about a $10 billion pharmaceutical company in Germany that makes small-molecule drugs and wants to enter the biologicals segment. The case asks whether GlobaPharm should acquire BioFuture, a 200-person, $1 billion publicly traded biologicals start-up in the San Francisco area.
What roles do PhDs and MDs apply for in consulting?
At McKinsey, professionals with PhDs, MDs, JDs, and other advanced degrees join from academia, research, or clinical practice into roles such as Associate, Fellow, or Summer Associate.
More guides
- Environmental Consulting Interview Questions and Answers
- McKinsey Acceptance Rate: Official Hiring Process & Stages
- Risk Consulting Interview Questions and Answers (2026)
- Consulting Presentation Slides: Structure, Charts & Build
- FTI Consulting Salary: Filings, Benchmarks & Pay (2026)
- Management Consulting Slide Deck: Structure and Guide
- CaseBasix Alternatives for Case Interview Prep (2026)
- Consulting Firm Hierarchy: Ranks at McKinsey, BCG and Bain
- Consulting Strategy Group: Services, Pay, and Vetting
- Deloitte Discovery Intern: How to Apply and Interview
- KPMG Verbal Reasoning Test: Format, Example and Prep
- Marketing and Strategy Consulting Firms Guide (2026)